U.S. Physical Therapy, Inc.
USPH
$74.75
$0.330.44%
NYSE
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 3.70% | -0.15% | |||
| Total Other Revenue | -0.17% | -0.16% | |||
| Total Revenue | 3.04% | -0.15% | |||
| Cost of Revenue | 2.52% | 3.26% | |||
| Gross Profit | 4.94% | -10.77% | |||
| SG&A Expenses | 4.08% | -0.35% | |||
| Depreciation & Amortization | -22.06% | -4.28% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 1.90% | 2.64% | |||
| Operating Income | 13.35% | -19.82% | |||
| Income Before Tax | -34.61% | 0.98% | |||
| Income Tax Expenses | 10.49% | 6.08% | |||
| Earnings from Continuing Operations | -47.99% | -0.44% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -11.50% | 15.45% | |||
| Net Income | -68.39% | 6.01% | |||
| EBIT | 13.35% | -19.82% | |||
| EBITDA | 5.53% | -16.60% | |||
| EPS Basic | -190.60% | -17.86% | |||
| Normalized Basic EPS | 24.99% | -27.29% | |||
| EPS Diluted | -190.60% | -17.86% | |||
| Normalized Diluted EPS | 24.99% | -27.29% | |||
| Average Basic Shares Outstanding | -0.24% | 0.05% | |||
| Average Diluted Shares Outstanding | -0.24% | 0.05% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | 2.16% | -0.53% | |||